tiprankstipranks
Trending News
More News >
Glenmark Pharmaceuticals Limited (IN:GLENMARK)
:GLENMARK
India Market
Advertisement

Glenmark Pharmaceuticals Limited (GLENMARK) Revenue

Compare
3 Followers

Glenmark Pharmaceuticals Limited Revenue

Glenmark Pharmaceuticals Limited had a revenue of 30.59B in the quarter ending Jun 30, 2025, with -10.46%. This bring the company's revenue in the last twelve months to 131.78B, Increased -1.38%. In the fiscal year ending Dec 31, 2025, Glenmark Pharmaceuticals Limited had annual revenue of 133.63B with 13.12% growth.
Revenue (ttm)
131.78B
Revenue Growth
10.99%
P/S Ratio
4.07
Revenue/Employee
₹8,915,401
Employees
14,989
Market Cap
₹543.41B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
133.63B15.50B+113.12%
Dec 31, 2024
118.13B2.30B+101.98%
Dec 31, 2023
115.83B-7.22B+94.14%
Dec 31, 2022
123.05B14.99B+113.87%
Dec 31, 2021
108.06B1.49B+101.40%
Dec 31, 2020
106.57B9.52B+109.81%
Dec 31, 2019
97.05B7.62B+108.51%
Dec 31, 2017
89.44B797.62M+100.90%
Dec 31, 2016
88.64B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis